Case Overview
The Delhi High Court on 29 July 2026 refused to halt the Centre’s ongoing HPV vaccination drive. The bench said the material placed before it did not show any immediate harm from the vaccine, while warning that “half‑baked vaccines” must not be administered without proper protocols.
Key Developments
- The bench of Chief Justice D.K. Upadhyaya and Justice Tejas Karia examined a PIL seeking a review of the HPV vaccine’s safety, consent and monitoring.
- Centre’s data showed 5.5 million doses administered to 14‑year‑old girls, with 120 adverse‑event reports, of which only 42 were “slightly aggravated” and no deaths.
- The court directed the Centre, the CDSCO and the ICMR to file separate replies within four weeks.
- The court emphasized that the vaccine is not part of the Universal Immunisation Programme and that informed consent from parents is mandatory.
Important Facts
• 5.5 million doses of the HPV vaccine have been given since the programme began on 28 February 2026.
• 120 adverse‑event reports were recorded; only 42 were minor, and there were no deaths.
• The petitioners cited a case from Tamil Nadu where a 14‑year‑old girl allegedly developed severe neurological symptoms within days of vaccination.
Exam Relevance
The case touches upon several topics that appear in the UPSC syllabus:
- Legal mechanisms for public health governance – understanding the role of Additional Solicitor General (ASG) Chetan Sharma in defending the policy.
- Regulatory framework for drugs and vaccines – the functions of CDSCO and ICMR.
- Public health policy – the voluntary nature of the HPV programme, informed consent, and its distinction from the UIP.
- Judicial review of health initiatives – the use of PIL to question vaccine safety.
Way Forward
The court’s order to file detailed replies gives the government a chance to present comprehensive safety data and monitoring mechanisms. Aspirants should watch for:
- Any subsequent orders from the bench after the 29 October hearing.
- Updates from CDSCO regarding post‑marketing surveillance of the HPV vaccine.
- Potential policy adjustments, such as stricter consent protocols or inclusion/exclusion from the UIP.
Understanding this interplay of health policy, legal oversight, and regulatory bodies is crucial for answering questions on public health governance in the UPSC exam.